维生素D3衍生物的侧链化工程用于VDR静音SREBP抑制剂
Fumihiro Kawagoe1, Sayuri Mototani1, Tomofumi Yatsu1
1Faculty of Pharmaceutical Sciences, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.
Chemical & pharmaceutical bulletin
|September 21, 2025
概括
研究人员开发了新的化维生素D3类似物,其目标是抑制固醇调节元素结合蛋白 (SREBP). 化合物11通过最小的维生素D受体 (VDR) 激活选择性抑制SREBP,提供了一个有前途的治疗途径.
科学领域:
- 药用化学 医学化学
- 分子药理学分子药理学
- 内分泌学 在内分泌学.
背景情况:
- 维生素D类型对各种生理过程至关重要.
- 选择性调节维生素D受体 (VDR) 和固醇调节元素结合蛋白 (SREBP) 途径具有治疗意义.
- 开发具有SREBP抑制活性的VDR静音类似物是一个关键的挑战.
研究的目的:
- 合成和表征新的化维生素D3类似物.
- 调查这些类似物在VDR和SREBP方面的结构-活动关系.
- 为了确定抑制SREBP而不激活VDR的类型.
主要方法:
- 合成侧链缩短和化维生素D3类似物 (化合物5-13).
- 生物活动的评估,包括对VDR带结合域 (VDR_LBD),全长VDR转录活性和SREBP转录活性的影响.
- 同类活性与25(OH) D3 (1) 的比较.
主要成果:
- 化合物8,11和13显示出显著的SREBP抑制活性.
- 与25(OH) D3.3相比,这些类型的强度较低.
- 化合物11显示出最有希望的选择性SREBP抑制与最小的VDR激活.
结论:
- 成功合成了新的化维生素D3类似物.
- 化合物11代表了选择性SREBP抑制的主要候选者.
- 这些发现为开发针对SREBP相关途径的VDR静音疗法铺平了道路.
更多相关视频
08:18Author Spotlight: Unraveling Vitamin A Transport Mechanisms — Linking Liver Receptors to Vision Health Through RBPR2 and RBP4 Interactions
Published on: October 4, 2024
1.5K
11:09Constructing Thioether/Vinyl Sulfide-tethered Helical Peptides Via Photo-induced Thiol-ene/yne Hydrothiolation
Published on: August 1, 2018
11.2K
相关概念视频
Role of Skin in Vitamin D Synthesis
7.6K
The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
7.6K
Transducer Mechanism: Nuclear Receptors
2.4K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.4K
Dipeptidyl Peptidase 4 Inhibitors
596
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
596
Drug-Receptor Bonds
4.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
4.2K
